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Wilms’ tumor is the second most common primary malignant intra-abdominal tumor in childhood. It is
derived from primitive metanephric blastema and characterized by histopathologic diversity. Alpha-
fetoprotein (AFP) is a typical oncofetal antigen of hepatic and germ cell tumors, particularly those
containing yolk sac elements. Herein, the rare case of elevated AFP level and fall following chemotherapy
has been described in a child with Wilms’ tumor. The subject on report is a two-year old male baby
detected with a palpable mass on the right side of the abdomen. His abdominal CT examinations revealed
a huge mass in the right kidney, with the possibility of nephroblastoma on the right side and shadow of
possible metastases in the left lung. Laboratory tests were within normal limits, but elevated serum
alpha-fetoprotein (238 ng/ml). Following this, he was given three courses of preoperative chemotherapy
actinomycin D, vincristine and pirarubicin (ACTD þ VCR þ THP). The result was that the level of AFP
decreased to 82.78 ng/ml after the ﬁrst two chemotherapy courses. He was then given third course of
chemotherapy, the AFP level decline to 1.87 ng/ml two days prior to right radical nephrectomy. Post-
operative AFP level was 1.42 ng/ml. One postoperative course of chemotherapy too was applied.
Consequently he was free of disease at the age of 4 years and 5 months with unremarkable AFP blood
value level.
 2014 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-ND license.Wilms’ tumor (WT) is the second most common primary ma-
lignant intra-abdominal tumor in childhood [1]. Its each cell type
may exhibit a spectrum of differentiation, generally replicating
various stages of renal embryogenesis consisting of blastemal,
stromal, and epithelial cells [2].
Alpha-fetoprotein (AFP) is a typical oncofetal antigen of hepatic
and germ cell tumors (i.e. hepatoblastoma, teratoblastoma, testic-
ular and ovaric carcinoma, sacrococcigeal teratomas), particularly
all containing yolk sac elements. Elevated levels, however, have also
been reported in adults with gastrointestinal tract, lung, and breast
neoplasms [3]. Some cases have been reported with the elevated
levels of AFP in Wilms’ tumor, either with teratoid or classic vari-
ants [4e6].
1. Case report
The subject on report here is a two-year old boy with a palpable
mass on the right side of the abdomen. Therewas no prior evidencesushildhungel@yahoo.com
Inc. Open access under CC BY-NC-ND of infection or hepatitis. He was admitted for evaluation and
management to Sun YatSen University, ﬁrst Afﬁliated Hospital.
Earlier, he was treated in another hospital with the complaint of a
huge abdominal mass on the right side. His CT examination (Fig. 1)
showed a huge mass in the right kidney, the possibility of blastoma
in the right kidney and shadow of metastases in the left lung.
He was then referred to the Zhongshan University Cancer
Hospital. His laboratory tests were within normal limits, but his
blood serum level of neuron-speciﬁc enolase (NSE) and alpha-
fetoprotein (AFP) showed 55.6 ng/ml and 238 ng/ml, respectively.
Likewise, his retroperitoneal tumor biopsy and pathological
diagnosis reported mixed type of Wilms’ tumor. Finally his clinical
diagnosis was made asWilms’ tumor stage IV. Next, he underwent
three courses of chemotherapy with actinomycin D, vincristine
and pirarubicin “ACTD þ VCR þ THP” which ran smooth with no
signiﬁcant adverse reactions. Upon reviewing CT after the course
of chemotherapy, the size of right kidney lesion had the size of
108 mm 98mm, which can be considered as post-chemotherapy
shrinkage. The left upper lung enhancement was 10 mm  11 mm
upon considering metastasis with multiple small lymph nodes in
bilateral supraclavicular region, bilateral axillary region, abdom-
inal aortic region and the bilateral inguinal region. Post-chemo-
therapy AFP level also decreased to 82.78 ng/ml, when the samelicense.
Fig. 1. Contrast enhanced computed tomography of the abdomen after chemotherapy
showed heterogenous mass in the mid and lower poles of the right kidney, Scanning
showed heterogenous low density, reﬂecting punctate calciﬁcation and low-density
necrotic area. Small patchy fat-like low-density lesions were also seen. The enhanced
scan showed the parenchymal phase mass signiﬁcantly heterogenous enhancement
capsule. The hyper-variable region strengthened obvious, medulla and renal pelvis
period continued to strengthen and normal renal parenchymal compression thinning
along with shift showed ring enhancement.
Fig. 2. Serum AFP Level of patient observed during the course of treatment in our
department. T1, time of 1st blood routine checkup in the 1st day of visit; T2, time of
2nd blood checkup after 3 courses of chemotherapy; T3, before nephrectomy; T4, post
surgical evaluation.
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went right radical nephrectomy. Six days later, it followed with the
level of AFP decrease to 1.42 ng/ml. Alpha-fetoprotein proﬁle of the
patient is shown in Fig. 2. On the eighth postoperative day he was
discharged. His histopathological lab reported an excised kidney as
Wilms’ tumors (epithelial type). After two weeks of surgery he
received one course of postoperative chemotherapy before being
discharged from the hospital. Recently again, he underwent a
surgery for pulmonary metastasis from another hospital.
Four years and ﬁve months later he was declared free of the
disease with unremarkable AFP blood value level.2. Pathology
2.1. Gross specimen and histopathology
Grossly (Fig. 3), the nephrectomy specimen weighed 510 g and
showed a solid spherical tumor measuring right renal size of about
14 cm  8 cm  7 cm, and tumor about 12  8  7 cm. Tumor
capsule was thick, tough, solid, near palpable and had lymph nodes.The cut surface was variegated with gray white, ﬁsh ﬂesh appear-
ance with cystic degeneration. The renal capsule was intact. There
was no involvement of the renal pelvis or vein.
Microscopically (Fig. 3), tumor-inﬁltration was with the destruc-
tion of the renal parenchyma. The part of the tumor cells were naive
glomeruloid or in glomerular-like structure. The epithelial element
comprised of short spindle and a small round, scattered in the
glomerular kind/tubular-like structure. Tumor inﬁltration read the
right adrenal below the right side of the inferior vena cava & lymph
nodes. No other area identiﬁed with the tumor inﬁltration in ureter
and lymph nodes.
Immunohistochemistry: Vimentin in (þ), CK (þ), WT-1 (þ), part
of the CD56 (þ), Desmin, NSE, CgA (), Syn (more wax block) ().
A ﬁnal diagnosis of specimen was Wilms’ tumor (epithelial
type).3. Discussion
Wilms’ tumor was named after the 19th century German sur-
geon Carl Max Wilhelm Wilms. It is probably derived from primi-
tive metanephric blastema. The histological appearance is
characterized by marked structural diversity. Classic Wilms’ tumor
is composed of three types of cells e blastemal, stromal, and
epithelial, although the occurrence of all three types in the same
case is uncommon [7].
Although elevated level of neuron speciﬁc enolase, carcinoem-
bryonic antigen, and hormone tumor markers, erythropoietin and
renin have been reported in WT. A very few cases of Wilms’ tumor
with the elevation of alpha-fetoprotein has been reported to date.
The level of elevated AFP in nephroblastoma was ﬁrst reported by
Roth et al. in 1984 [8]. So far to our knowledge, there are only four
cases reported with elevated AFP in Wilms’ tumor with the classic
type [4,8e10]. Similarly, elevated AFP has been found in teratoid
Wilms’ tumor, which has a predominance of teratoid elements
consisting of more than 50% of the tumor. This type of teratoid
Wilms’ tumor with elevated AFP return to normal after nephrec-
tomy was reported in teratoid WT by Ashworth et al. [5]. In this
case, the source of elevated AFP was demonstrated by immuno-
histochemistry as the AFP containing cysts lined by enteric-type
epithelium within the tumor. In this particular case, teratoid ele-
ments and enteric foci were not observed.
Patriarca et al. in 1992 had described about a case of Wilms’
tumor with elevated AFP. In that report the tumor did not show
regression either on clinical or pathologic assessments, and serum
AFP levels decreased upon preoperative chemotherapy, but
Fig. 3. Resected kidney with cystic degeneration. Partially differentiated inﬁltrating destruction of the renal parenchyma.
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similar to ours, as our case showed a dimensional regression upon
preoperative chemotherapy when AFP level too decreased, which
later returned to normal level after nephrectomy. Similarly Kismet
Erol in 2005, A. Crocoli in 2008 and V. Kesik et al. in 2010 had re-
portedWilms’ tumor with elevated AFP level, which later returned
to normal level just after nephrectomy. AFP values were far higher
inpatientswithmetastatic disease than in the onewith thrombosis
of inferior vena cava [10]. As in our case the metastasis was only
found in lungs.
Like any elevated tumor marker, elevated AFP by itself is not
diagnostic, but is only suggestive. Tumor markers are used pri-
marily tomonitor the results of a treatment. If levels of AFP go down
after treatment, the tumor shows not growing. In the case of babies,
after treatment AFP should go down faster than it would normally.
A temporary increase in AFP immediately following chemotherapy
may indicate not that the tumor is growing, but rather that it is
shrinking. Rare AFP-secreting tumor types include carcinoma in a
mixed Müllerian tumor [11]. The Sertoli-Leydig cell tumor, which
itself is rare, rarely secretes AFP [12]. In Wilms’ tumor AFP is rarely
elevated, but when it is elevated, it may be read as a marker of
disease progression or recurrence [10]. Increased serum levels of
alpha-fetoprotein are sometimes found in Citrullinemia and Argi-
ninosuccinate synthetase deﬁciency [13].4. Conclusion
Usually, there are no criteria for performing the routine serum
AFP sampling in renal tumor due to its easy clinical diagnosis. Due
to this, chance was that the past had missed a large number of
elevated AFP level cases of Wilms’ tumor. After the diagnosis of this
case, we sent the investigation report of all new patients with
Wilms’ tumor. Here then no other such case was reported existing
with the elevated AFP level. We rather recommend now sendingAFP level in all cases with renal tumor as the ﬁrst line of
investigation.
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